AnalystBook Research · Company Intelligence

Douglas Emmett Inc

DEINYSE

Built from Douglas Emmett Inc's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Revenue increased 1.8% to $1.00B, while Net income decreased 30.8% to $16.3M.

The read at a glance✓ Audited against SEC data
  • ScaleFY2025 revenue $1.00BOK
  • ProfitabilityNet income $16.3MOK
  • Cash generationFree cash flow N/ANote
  • AccountingNo applicable forensic screenNote
  • Insiders3 buys; 0 sells in 365 daysOK
  • Capitaldividends paid were $127.3M; share repurchases were $0Note

Business

Douglas Emmett Inc: In-Service Portfolio Represents our Total Portfolio excluding properties in our Development Portfolio.

Where the revenue comes from

Fiscal 2025, as Douglas Emmett Inc reports it. History and quarterly detail are in the app.

  • Office rental$805.5M
  • Multifamily rental$198.5M

Leadership changes

From Douglas Emmett Inc's own filings, the day they're filed.

  • Leslie E. Bider · director · departureeff. 2026-04-06
  • Dan A. Emmett · Chairman · departureeff. 2023-08-24
  • M. Arthur Gensler Jr · directors · appointment

Latest filings

  • 10-Q · Quarterly report2026-08-07
  • 8-K · Company announcement2026-08-04
  • 8-K · Company announcement2026-06-03
  • 10-Q · Quarterly report2026-05-08
  • 8-K · Company announcement2026-05-05
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Douglas Emmett Inc, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.